It is a pharma private limited company based in Ranchi, Jharkhand, India, established in 2011.
2011 | Ranchi, Jharkhand, India | ActiveProlipsi Pharmaceutical Private Limited, a active private limited company, was established on 06 June 2011 in Ranchi, Jharkhand, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397JH2011PTC014899. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shyam Kishore Pathak (Director), Kumar Kaushal Kishor (Director). Past directors included Sujeet Kumar. It holds ₹0.65 M open charges and no settled loans. Its latest AGM occurred on 28 October 2023, with the balance sheet filed on 31 March 2023. It is based at Malti Complex, Near Tulsi Apartment Bariatu Road, Booty More, Ranchi, Jharkhand, 834009.
U51397JH2011PTC014899
014899
06 June 2011
₹0.50 M
₹0.10 M
Roc Ranchi
Unlisted
Active
Explore comprehensive insights into Prolipsi Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shyam Kishore Pathak | Director | 06 Jun 2011 | Current |
| Kumar Kaushal Kishor | Director | 06 Jun 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Oct 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Prolipsi Pharmaceutical Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 10.51% increase. The company also saw a substantial improvement in profitability, with a 94.63% increase in profit. The company's net worth Soared by an impressive increase of 37.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Prolipsi Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹650,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2014 | Idbi Bank Limited | ₹0.65 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Prolipsi Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Prolipsi Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prolipsi Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Prolipsi Pharmaceutical Private Limited last Annual general meeting of members was held on 28 Oct 2023 as per latest MCA records. was documented.
Progress on Prolipsi Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ranchi. was documented.
The activity A charge with Idbi Bank Limited amounted to Rs. 0.65 M with Charge ID 10568772 was registered on 17 Dec 2014. was completed.
Shyam Kishore Pathak was appointed as a Director was appointed as a Director on 06 Jun 2011 & has been associated with this company since 14 years 5 months . was recorded as a recent event.
Progress on Kumar Kaushal Kishor was appointed as a Director was appointed as a Director on 06 Jun 2011 & has been associated with this company since 14 years 5 months . was documented.
Prolipsi Pharmaceutical Private Limited was registered on 06 Jun 2011 with Roc Ranchi & aged 14 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Prolipsi Pharmaceutical Private Limited is U51397JH2011PTC014899.
Prolipsi Pharmaceutical Private Limited is headquartered at Malti Complex, Near Tulsi Apartment Bariatu Road, Booty More, Ranchi, Jharkhand, 834009.
Prolipsi Pharmaceutical Private Limited was incorporated on 06 June 2011.
The current directors of Prolipsi Pharmaceutical Private Limited are
The primary industry of Prolipsi Pharmaceutical Private Limited is Trade.
Prolipsi Pharmaceutical Private Limited is unlisted.
The authorized capital of Prolipsi Pharmaceutical Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Prolipsi Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX